ORYZON to present at upcoming international conferences
MADRID, SPAIN and CAMBRIDGE MA.
- BioMed Event, Paris, France
- 6th Annual LSX World Congress 2020, London, UK
- Bio-CEO & Investor Conference, New York, USA
- 13th Annual European LifeSciences CEO Forum, Zurich, Switzerland
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that Executive Directors of the company will present at several reputed international conferences in January-February.